Status:
COMPLETED
Evaluation and Optimization of Hearing Devices in 3-D Complex Audio Environments Study 2
Lead Sponsor:
Sonova AG
Collaborating Sponsors:
Swiss Commission for Technology and Innovation
Conditions:
Ability, Spatial
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
A methodical evaluation of novel sound changing principles in CE-labelled Sonova brand hearing instruments (e.g. Phonak hearing instruments) is intended to be conducted on hearing impaired participant...
Eligibility Criteria
Inclusion
- Adult persons (minimum age: 18 years) with Hearing loss
- Healthy outer ear (without previous surgical procedures)
- Ability to fill in a questionnaire conscientiously
- Informed Consent as documented by signature
Exclusion
- Contraindications to the MD in this study, e.g. known hypersensitivity or allergy to the investigational product
- Limited mobility and not in the position to attend weekly appointments
- Limited ability to describe listening impressions/experiences and the use of the hearing aid
- Inability to produce a reliable hearing test result
- Massively limited dexterity
- Known psychological problems
- Known central hearing disorders
Key Trial Info
Start Date :
October 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 21 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03774030
Start Date
October 9 2018
End Date
January 21 2019
Last Update
May 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Switzerland, 8091